Reduced levels of immunoglobulin in children with autism correlateswith behavioral symptoms

Autism Research

Volumn 1, Issue 5, 2008, Pages 275-283

  Heuer, Luke ^a   Ashwood, Paul ^a,b   Schauer, Joseph ^a   Goines, Paula ^a   Krakowiak, Paula ^a   Hertz Picciotto, Irva ^a   Hansen, Robin ^a,b   Croen, Lisa A ^c   Pessah, Isaac N ^a   Van De Water, Judy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

Author keywords

Autism; Behavior; IgG; Immunoglobulin

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; AUTISM; BLOOD; CHILD; FEMALE; HUMAN; IMMUNOLOGY; MALE; MENTAL DISEASE; PRESCHOOL CHILD;

AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MENTAL DISORDERS;

EID: 61549118828     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.42     Document Type: Article

References (51)

1. Aksu, G., Genel, F., Koturoglu, G., Kurugol, Z.,&Kutukculer, N. (2006). Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: a study using nephelometric technique. Turkish Journal of Pediatrics, 48, 19-24.
2. APA (1994). Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Association.
3. Ashwood, P., Anthony, A., Pellicer, A.A., Torrente, F., Walker-smith, J.A.,&Wakefield, A.J. (2003). Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. Journal of Clinical Immunology, 23, 504-517.
4. Ashwood, P., Wills, S.,&Van de Water, J. (2006). The immune response in autism: a new frontier for autism research. Journal of Leukocyte Biology, 80, 1-15.
5. Biber, K., Zuurman, M.W., Dijkstra, I.M.,&Boddeke, H.W.G.M. (2002). Chemokines in the brain: neuroimmunology and beyond. Current Opinion in Pharmacology, 2, 63.
6. Boccone, L., Dessi, V., Zappu, A., Piga, S., Piludu, M.B., et al. (2006). Bannayan-Riley-Ruvalcaba syndrome with reactive nodular lymphoid hyperplasia and autism and a PTEN mutation. American Journal of Medical Genetics, Part A, 140, 1965-1969.
7. Brynskikh, A., Warren, T., Zhu, J.,&Kipnis, J. (2008). Adaptive immunity affects learning behavior in mice. Brain, Behavior, and Immunity, 22, 861-869.
8. Butler, M.G., Dasouki, M.J., Zhou, X.P., Talebizadeh, Z., Brown, M., et al. (2005). Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. Journal of Medical Genetics, 42, 318-321.
9. Campbell, D.B., D'Oronzio, R., Garbett, K., Ebert, P.J., Mirnics, K., et al. (2007). Disruption of cerebral cortex MET signaling in autism spectrum disorder. Annals of Neurology, 62, 243-250.
10. Campbell, D.B., Sutcliffe, J.S., Ebert, P.J., Militerni, R., Bravaccio, C., et al. (2006). A genetic variant that disrupts MET transcription is associated with autism. Proceedings of the National Academy of Sciences of the United States of America, 103, 16834-16839.
11. Croonenberghs, J., Wauters, A., Devreese, K., Verkerk, R., Scharpe, S., et al. (2002). Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychological Medicine, 32, 1457-1463.
12. Di Lavore, P.C., Lord, C.,&Rutter, M. (1995). The pre-linguistic autism diagnostic observation schedule. Journal of Autism and Developmental Disorders, 25, 355-379.
13. Edinburgh. 2000. www.cgmh.org.tw/intr/intr1/c0040/web/C/Declaration%20of%20Helsinki.pdf.
14. Engstrom, A.H., Ohlson, S., Stubbs, E.G., Maciulus, A., Caldwell, V., et al. (2003). Decreased expression of CD95 (FAS/APO-1) on CD41 T-lymphocytes from participants with autism. Journal of Developmental and Physical Disabilities, 15, 155-163.
15. Ginel, P.J., Margarito, J.M., Lucena, R.,&Molleda, J.M. (1997). Concentrations of plasma immunoglobulins in the dog as determined by laser nephelometry. Comparison with radial immunodiffusion and enzyme-linked immunosorbent assay.European Journal of Clinical Chemistry and Clinical Biochemistry, 35, 223-228.
16. Goffin, A., Hoefsloot, L.H., Bosgoed, E., Swillen, A.,&Fryns, J.P. (2001). PTEN mutation in a family with Cowden syndrome and autism. American Journal of Medical Genetics, 105, 521-524.
17. Gupta, S., Aggarwal, S.,&Heads, C. (1996). Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. Journal of Autism and Developmental Disorders, 26, 439-452.
18. Gupta, S., Rimland, B.,&Shilling, P. D. (1996). Pentoxifylline: brief review and rationale for its possible use in the treatment of autism. Journal of Child Neurology, 11, 501-504.
19. Haddad, J.J., Saade, N.E.,&Safieh-garabedian, B. (2002). Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. Journal of Neuroimmunology, 133, 1-19.
20. Hansen, R.L., Ozonoff, S., Krakowiak, P., Angkustsiri, K., Jones, C., et al. (2008). Regression in autism: prevalence and associated factors in the CHARGE study. Ambulatory Pediatrics, 1, 25-31.
21. Hertz-picciotto, I., Croen, L.A., Hansen, R., Jones, C.R., Van de Water, J.,&Pessah, I.N. (2006). The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environmental Health Perspectives, 114, 1119-1125.
22. Hogan, D., Morrow, J.D., Smith, E.M.,&Opp, M.R. (2003). Interleukin-6 alters sleep of rats. Journal of Neuroimmunology, 137, 59-66.
23. Huh, G.S., Boulanger, L.M., Du, H., Riquelme, P.A., Brotz, T.M.,&Shatz, C.J. (2000). Functional requirement for class I MHC in CNS development and plasticity. Science, 290, 2155-2159.
24. Janeway, C.A., Travers, P., Walport, M.,&Shlomchik, M.J. (2005). Immunobiology: the immune system in health and disease. New York: Garland Science Publishing.
25. Joseph, R.M., Tager-flusberg, H.,&Lord, C. (2002). Cognitive profiles and social-communicative functioning in children with autism spectrum disorder. Journal of Child Psychology and Psychiatry and Allied Disciplines, 43, 807-821.
26. Jyonouchi, H., Sun, S.,&Le, H. (2001). Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. Journal of Neuroimmunology, 120, 170-179.
27. Kwon, C.H., Luikart, B.W., Powell, C.M., Zhou, J., Matheny, S.A., et al. (2006). Pten regulates neuronal arborization and social interaction in mice. Neuron, 50, 377-388.
28. Larson, S.J. (2002). Behavioral and motivational effects of immune-system activation. Journal of General Psychology, 129, 401-414.
29. Lord, C., Leventhal, B.L.,&Cook Jr., E.H. (2001). Quantifying the phenotype in autism spectrum disorders. American Journal of Medical Genetics, 105, 36-38.
30. Lord, C., Pickles, A., McLennan, J., Rutter, M., Bregman, J., et al. (1997). Diagnosing autism: analyses of data from the Autism Diagnostic Interview. Journal of Autism and Developmental Disorders, 27, 501-517.
31. Marques-deak, A., Cizza, G.,&Sternberg, E. (2005). Brain-immune interactions and disease susceptibility. Molecular Psychiatry, 10, 239-250.
32. Mehler, M.F.,&Kessler, J.A. (1998). Cytokines in brain development and function. Advances in Protein Chemistry, 52, 223-251.
33. Mignini, F., Streccioni, V.,&Amenta, F. (2003). Autonomic innervation of immune organs and neuroimmune modulation. Autonomic and Autacoid Pharmacology, 23, 1-25.
34. MMWR. (2007). Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveillance Summary, 56, 12-28.
35. Mullen, E. (1995). The Mullen Scales of Early Learning. Circle Pines, MN: American Guidance Service.
36. Owley, T., McMahon, W., Cook, E.H., Laulhere, T., South, M., et al. (2001). Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1293-1299.
37. Ozonoff, S., Williams, B.J.,&Landa, R. (2005). Parental report of the early development of children with regressive autism: the delays-plus-regression phenotype. Autism, 9, 461-486.
38. Raux, M., Finkielsztejn, L., Salmon-ceron, D., Bouchez, H., Excler, J.L., et al. (1999). Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects. AIDS Research and Human Retroviruses, 15, 1365-1376.
39. Rothwell, N.J., Luheshi, G.,&Toulmond, S. (1996). Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology. Pharmacology&Therapeutics, 69, 85-95.
40. Sparrow, S.S., Balla, D.A.,&Cicchetti, D.V. (1984). Vineland adaptive behavior scales. Circle Pines, MN: American Guidance Service.
41. Splawski, I., Timothy, K.W., Sharpe, L.M., Decher, N., Kumar, P., et al. (2004). Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell, 119, 19-31.
42. Steinhausen, H.C.,&Erdin, A. (1992). Abnormal psychosocial situations and ICD-10 diagnoses in children and adolescents attending a psychiatric service. Journal of Child Psychology and Psychiatry, 33, 731-740.
43. Steinman, L. (2004). Elaborate interactions between the immune and nervous systems. Nature Immunology, 5, 575-581.
44. Stern, L., Francoeur, M.J., Primeau, M.N., Sommerville, W., Fombonne, E.,&Mazer, B.D. (2005). Immune function in autistic children. Annals of Allergy, Asthma&Immunology, 95, 558-565.
45. Sweeten, T.L., Bowyer, S.L., Posey, D.J., Halberstadt, G.M.,&McDougle, C.J. (2003). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics, 112, e420.
46. Trajkovski, V., Ajdinski, L.,&Spiroski, M. (2004). Plasma concentration of immunoglobulin classes and subclasses in children with autism in the Republic of Macedonia: retrospective study. Croatian Medical Journal, 45, 746-749.
47. Warren, R.P., Foster, A.,&Margaretten, N.C. (1987). Reduced natural killer cell activity in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 333-335.
48. Warren, R.P., Odell, J.D., Warren, W.L., Burger, R.A., Maciulis, A., et al. (1997). Brief report: immunoglobulin A deficiency in a subset of autistic subjects. Journal of Autism and Developmental Disorders, 27, 187-192.
49. Warren, R.P., Yonk, L.J., Burger, R.A., Cole, P., Odell, J.D., et al. (1990). Deficiency of suppressor-inducer (CD41CD45RA1) T cells in autism. Immunological Investigations, 19, 245-251.
50. Wrona, D. (2006). Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. Journal of Neuroimmunology, 172, 38-58.
51. Ziv, Y., Ron, N., Butovsky, O., Landa, G., Sudai, E., et al. (2006). Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nature Neuroscience, 9, 268-275.